-
This study documents the safety and efficacy of oral polyethylene glycol for the long-term treatment of chronic constipation.
-
In a systematic review and meta-analysis of worldwide data on the placement of ureteral stents after ureteroscopy in patients with kidney stones, the authors found higher morbidity with lower urinary tract problems ...
-
Limiting dietary sodium can reduce blood pressure and morbidity and mortality from cardiovascular disease.
-
In this article, the ECG in the Figure was obtained from a 33-year old man who was admitted to the hospital with atypical chest pain.
-
Almost 90% of persons with type 2 diabetes (DM2) are overweight. Weight loss in DM2 consistently results in meaningful favorable changes in lipids, glucose, and insulin resistance, so the clinical community embraces tools to enhance weight loss in this population.
-
The FDA has approved the first continuous, low dose, oral contraceptive for the prevention of pregnancy.
-
Statin-treated patients who developed symptoms of myopathy should be treated with at least 100 mg daily of coenzyme Q10 for a minimum of 30 days (assuming CPK values and/or other liver function tests are not abnormal) before discontinuing statin therapy.
-
Robert Hatcher, MD, MPH, professor of obstetrics and gynecology at Atlanta's Emory University and chairman of the editorial board for Contraceptive Technology Update, is the 2007 recipient of the Kenneth J. Ryan, MD, Physician Leadership Award.
-
Results of a large national study of young men and women ages 18-27 suggest that Mycoplasma genitalium, a relatively new sexually transmitted infection, surpassed gonorrhea in prevalence.
-
Obesity is gaining ground in the United States. Are you prepared to offer women effective options? James Trussell, PhD, professor of economics and public affairs and director of the Office of Population Research at Princeton (NJ) University, reviewed current research at the 2007 Contraceptive Technology conferences to help clinicians select appropriate options.